Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Unibiotest, commonly referenced as Wuhan Unibiotest Co., Ltd., appears to be a China-based diagnostics and life science tools company focused on immunoassay reagents, biological systems, and related laboratory products. Third-party company directories describe it as a manufacturer of diagnostic equipment and reagents, with a catalog spanning antibodies, antigens, biochemicals, ELISA kits, CLIA kits, laboratory equipment, and rapid test products. Product listings indicate commercialized assay kits for food contaminants and species identification, suggesting the company operates primarily as a reagent and test-kit supplier rather than a therapeutic drug developer. Available evidence points to a commercial-stage business serving research, testing, and diagnostic markets, with operations centered in Wuhan, China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Unibiotest.